Asthma Trials in Fukuoka, Japan
Conditions / Asthma / Fukuoka, Japan
Asthma has been the subject of sustained clinical investigation across multiple research sites.
56 total trials for this combination
Showing top 10 of 56 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT06023589 | A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma | RECRUITING | — |
| NCT04609878 | Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS) | COMPLETED | PHASE3 |
| NCT02134028 | Long-Term Safety Evaluation of Dupilumab in Patients With Asthma (LIBERTY ASTHMA TRAVERSE) | COMPLETED | PHASE3 |
| NCT02924688 | A Phase III Parallel Group Study, Comparing the Efficacy, Safety and Tolerability of the Fixed Dose Combination (FDC) of Fluticasone Furoate+Umeclidinium Bromide+Vilanterol (FF/UMEC/VI) With the FDC of FF/VI in Subjects With Inadequately Controlled Asthma | COMPLETED | PHASE3 |
| NCT02760329 | Observational Study of Obstructive Lung Disease (NOVELTY) | COMPLETED | — |
| NCT02258542 | A Safety Extension Study to Evaluate the Safety and Tolerability of Benralizumab (MEDI-563) in Asthmatic Adults and Adolescents on Inhaled Corticosteroid Plus LABA | COMPLETED | PHASE3 |
| NCT04718389 | A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype | COMPLETED | PHASE3 |
| NCT02414854 | Evaluation of Dupilumab in Patients With Persistent Asthma (Liberty Asthma Quest) | COMPLETED | PHASE3 |
| NCT06023589 | A Study to Investigate the Efficacy and Safety of Tezepelumab Compared With Placebo in Children 5 to < 12 Years Old With Severe Asthma | RECRUITING | — |
| NCT03347279 | Study to Evaluate Tezepelumab in Adults & Adolescents With Severe Uncontrolled Asthma | COMPLETED | PHASE3 |